Healthcare Technology M&A Advisors
Nelson Advisors specialise in mergers, acquisitions and partnerships for Digital Health, HealthTech, Health IT, Healthcare Cybersecurity and Healthcare AI companies based in the UK, Europe and North America Nelson Advisors LLP, Hale House, 76-78 Portland Place, London, W1B 1NT
Healthcare Technology Mergers, Acquisitions, Partnerships
'Build, Buy, Partner, Sell'
Our team of successful healthcare technology founders and senior executives have built, pivoted and scaled HealthTech businesses since 2012, securing exits from North American, European and FTSE listed companies. With a deep understanding of the healthcare technology market landscape in the UK and across Europe, we provide tailored solutions to our clients that drive sustainable success.
Whether you need assistance with mergers and acquisitions, channel partnerships, investment due diligence or growth strategies, Nelson Advisors are your reliable Healthcare Technology partner and advisor. We work with our UK, European and North American clients to assess whether they should 'Build, Buy, Partner or Sell' in order to maximise shareholder value and investment returns, with average client engagements lasting 4 to 7 months.
'Founders for Founders' > we pride ourselves on our DNA as HealthTech entrepreneurs advising HealthTech entrepreneurs.
Our Founding Partners have built, scaled and exited 4 HealthTech businesses in the Patient Engagement, Medical Device Cybersecurity, Metabolic Health and Consumer Health markets. In addition to founding HealthTech businesses, they have served on a wide range of company boards ranging from Veterinary TeleHealth to Digital MSK to Community Workforce Management to Wearable Tech to Healthcare AI to D2C Healthcare.
M&A
Buy Side
Sell Side
Corporate Divestitures
Roll Up Strategies
Tech Asset Sales
Strategy
Go To Market
UK Market Entry
International Expansion
Channel Partnerships
Joint Ventures
Digital Health, HealthTech, Health IT, Healthcare Cybersecurity, Healthcare AI
Digital Health: Encompasses all digital technologies used in healthcare and wellness. This broad field includes everything from mobile apps and telehealth to wearable devices and health information tools. The goal is to improve patient engagement, health outcomes, and healthcare delivery.
HealthTech: Focuses on technological innovations within healthcare to improve patient outcomes and healthcare delivery. It emphasizes the technologies themselves, such as advanced medical devices, AI, robotics, bioprinting, and nanotechnology. HealthTech is often associated with startups and tech companies developing new solutions to healthcare challenges.
Health IT: Focuses on the technology used to manage, store, and share health information. This includes systems like electronic health records, health information exchanges, and clinical decision support tools. The goal is to improve the accuracy, efficiency, and accessibility of health information to enhance patient care and administrative processes.
Healthcare Cybersecurity: Aims to ensure the confidentiality, integrity, and availability of healthcare information and systems, thereby safeguarding patient safety and maintaining trust. Medical device cybersecurity encompasses the practices and technologies used to safeguard medical devices and their connected systems from unauthorised access, manipulation, or disruption.
Healthcare AI: Healthcare Artificial Intelligence, refers to the application of AI technologies in the field of healthcare to improve medical diagnosis, treatment, patient care, and operational efficiency. It involves the use of algorithms, machine learning, natural language processing, and other AI techniques to analyse complex medical data, identify patterns and provide insights or recommendations to healthcare professionals and patients.
'We partner with entrepreneurs, boards and investors to maximise shareholder value and investment returns.'
HealthTech Market Research & Predictions
Click here to read '2025 UK HealthTech Predictions – Big 5 for 2025'
Click here to read 'HealthTech M&A valuation multiples: 10 Key Variables in 2025'
Click here to read '2025 is shaping up to be a pivotal year for the "Digital Left Shift" in UK HealthTech'
Click here to read 'Technology > Methodology > Cogniology : HealthTech's 3 Waves and 30 Year Journey'
Click here to read 'What type of Healthcare AI companies are being funded and acquired in 2025?'
Click here to read 'Hardware, Software, Apps, Devices: Where could UK HeathTech be hit the hardest with US tariffs?'
Click here to read 'OCR + Ambient Voice + Generative AI = Future Billion Dollar HealthTech Startup'
Nelson Advisors specialise in mergers, acquisitions and partnerships for Digital Health, HealthTech, Health IT, Healthcare Cybersecurity and Healthcare AI companies based in the UK, Europe and North America
Partners
Our Founding Partners have built, scaled and exited 4 HealthTech businesses since 2012 in the Patient Engagement, Medical Device Cybersecurity, Metabolic Health and Consumer Health markets. They both regularly mentor MBA, MPhil/PhD students, guest lecture and speak at leading University Business Schools and societies across the UK including University College London, Oxford, Cambridge and London Business School.
Lloyd Price
Lloyd is a Partner and Co-Founder of Nelson Advisors. He brings 12+ years of successful HealthTech entrepreneurial experience having founded and exited various companies including Zesty in 2020 to Induction Healthcare Group PLC (FTSE:INHC). Prior to his HealthTech ventures, Lloyd held senior business development, marketing, strategy and corporate development roles at Kelkoo, Yahoo! UK, Yahoo! Europe and Badoo/Bumble.
Lloyd is a Health Executive in Residence at the UCL Global Business School for Health, Mentor for Oxford Venture Capital Network, Oxford MedTech Society. He was a Founder of The Future Health community in 2024, Founding Member of the Digital Healthcare Council in 2017 and Committee Member for the Coalition for a Digital Economy promoting the interests of UK startups.
Lloyd led the Coadec-TechUK delegation sent to the European Parliament in Brussels in Sept 2015 and March 2016 to discuss the General Data Protection Regulation and what the UK Tech sector needs from the EU Digital Single Market.
Lloyd was asked to judge the Digital Health Pitchfest Awards in 2022, 2023 and the HealthInvestor Awards 2024, 2025. He was asked to be a panellist and speaker at Citi's European Internet & Digital Conference 2016, McKinsey 5th Annual Digital Health Conference 2022 and the Economist MedTech Debate in 2013.
HealthTech exits > 2020 and 2024
Paul Hemings
Paul is a Partner and Co-Founder of Nelson Advisors. He brings more than a decade of global M&A and capital raising expertise, and 10 years of entrepreneurial experience having founded and exited from 2 early-stage companies, most recently in metabolic HealthTech. Prior to his early-stage ventures,
Paul held investment and strategy roles at Invesco, and senior investment banking advisory roles at Credit Suisse where his transaction experience included over £50 Billion of M&A and £40 Billion of equity/financing. Paul remains an active Board Advisor to a number of early-stage tech companies across the health/med tech, fintech and consumer sectors. Paul has an honours degree in Economics from Queen’s University (Canada) and an MBA from London Business School.
His extensive corporate finance experience includes $50+ Billion of Mergers & Acquisitions and $40+ Billion equity/financing transactions across US, UK, Ireland, Sweden, Denmark, Switzerland, Germany, Austria, Italy, Poland, Ukraine, Russia, Kazakhstan, Hong Kong, Singapore and Australia.
As Co-Founder of Neutrally, Paul focused on intercepting chronic lifestyle disease with data-led habit change around nutrition, exercise, sleep + mental well-being. His research led to the commercial application of the future of weight management, wellness & longevity.
HealthTech exits > 2019 and 2024
Contact Us:
Fill out the contact form below to get in touch with our team. We are here to answer any questions and provide assistance for all your corporate development needs.